Jan 25 (Reuters) - European Medicines Agency:
* EMA PUBLISHED CLINICAL DATA SUPPORTING EXTENSION OF INDICATION FOR SPIKEVAX TO INCLUDE USE IN ADOLESCENTS AGED 12 TO 17. Further company coverage:
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
108 USD | +1.69% | +6.47% | +8.57% |
Apr. 24 | Sector Update: Health Care Stocks Slipping Late Afternoon | MT |
Apr. 24 | Moderna to Collaborate With OpenAI to Launch New Generation of Medicines | MT |
Jan 25 (Reuters) - European Medicines Agency:
* EMA PUBLISHED CLINICAL DATA SUPPORTING EXTENSION OF INDICATION FOR SPIKEVAX TO INCLUDE USE IN ADOLESCENTS AGED 12 TO 17. Further company coverage:
1st Jan change | Capi. | |
---|---|---|
+8.57% | 40.65B | |
+1.51% | 42.59B | |
+49.22% | 40.57B | |
-12.36% | 26.77B | |
+8.92% | 24.81B | |
-25.13% | 18.17B | |
+29.17% | 12.05B | |
-3.12% | 11.7B | |
+6.35% | 11.1B | |
-16.98% | 9.85B |